A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy
NCT04230044 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 117
Last updated 2020-01-18
Summary
The purpose of the study is to evaluate the safety and efficacy of Fycompa® (perampanel) for the adjunctive treatment of partial-onset seizures with or without secondarily generalized seizures in participants with epilepsy aged 12 years and older.
Conditions
- Epilepsy
- Partial-onset Seizures
Interventions
- DRUG
-
Perampanel
Perampanel tablets.
Sponsors & Collaborators
-
Eisai Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-11
- Primary Completion
- 2017-07-03
- Completion
- 2017-07-03
More Related Trials
-
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
NCT03059381 ·Status: COMPLETED
-
A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures
NCT04257604 ·Status: COMPLETED
-
A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy
NCT04252846 ·Status: COMPLETED
-
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
NCT03208660 ·Status: COMPLETED
-
The Efficacy of Fycompa (Perampanel) in Children With Epilepsy
NCT04608799 ·Status: COMPLETED
-
Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy
NCT02736162 ·Status: COMPLETED
-
A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older
NCT03836924 ·Status: COMPLETED
-
A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy
NCT04015141 ·Status: RECRUITING ·Phase: PHASE2
-
An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects
NCT02427607 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures
NCT02220972 ·Status: WITHDRAWN ·Phase: PHASE4
-
Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
NCT02727101 ·Status: TERMINATED ·Phase: PHASE4
-
Perampanel in Focal Status Epilepticus
NCT04309721 ·Status: TERMINATED ·Phase: PHASE3
-
A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents
NCT01161524 ·Status: COMPLETED ·Phase: PHASE2
-
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
NCT02849626 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
NCT03288129 ·Status: COMPLETED ·Phase: PHASE4
-
A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
NCT01393743 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs
NCT01527006 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Intravenous Perampanel in Japanese Participants With Epilepsy
NCT03754582 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
NCT00699582 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
NCT02834793 ·Status: TERMINATED ·Phase: PHASE3
-
A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures
NCT01618695 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
NCT05684978 ·Status: TERMINATED ·Phase: PHASE4
-
Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization
NCT02726074 ·Status: COMPLETED ·Phase: PHASE4
-
Perampanel in Seizure Patients With Primary Glial Brain Tumors
NCT02363933 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
NCT00699972 ·Status: COMPLETED ·Phase: PHASE3